These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 8895749)
1. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749 [TBL] [Abstract][Full Text] [Related]
2. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene. Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965 [TBL] [Abstract][Full Text] [Related]
4. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats. Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Selcer KW; Hegde PV; Li PK Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848 [TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol. Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235 [TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE. Purohit A; Woo LW; Potter BV; Reed MJ Cancer Res; 2000 Jul; 60(13):3394-6. PubMed ID: 10910045 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase. Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity. Shields-Botella J; Bonnet P; Duc I; Duranti E; Meschi S; Cardinali S; Prouheze P; Chaigneau AM; Duranti V; Gribaudo S; Rivière A; Mengual L; Carniato D; Cecchet L; Lafay J; Rondot B; Sandri J; Pascal JC; Delansorne R J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):327-35. PubMed ID: 12711019 [TBL] [Abstract][Full Text] [Related]
10. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models. Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815 [TBL] [Abstract][Full Text] [Related]
11. The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase. Ahmed S; James K; Owen CP Biochem Biophys Res Commun; 2002 May; 294(1):180-3. PubMed ID: 12054760 [TBL] [Abstract][Full Text] [Related]
13. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells. Walter G; Liebl R; von Angerer E J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451 [TBL] [Abstract][Full Text] [Related]
14. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Woo LL; Purohit A; Malini B; Reed MJ; Potter BV Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081 [TBL] [Abstract][Full Text] [Related]
15. The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse. Nicolas LB; Fry JP Brain Res; 2007 Oct; 1174():92-6. PubMed ID: 17868658 [TBL] [Abstract][Full Text] [Related]
16. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785 [TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy. Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691 [TBL] [Abstract][Full Text] [Related]
18. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy. Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. Billich A; Nussbaumer P; Lehr P J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]